WSJ US BusinessAstraZeneca-Oxford Vaccine Up to 90% Effective in Trials

November 23, 20200
http://www.gmi-co.com/wp-content/uploads/2020/11/astrazeneca-oxford-vaccine-up-to-90-effective-in-trials.jpg

LONDON—AstraZeneca PLC and the University of Oxford added their vaccine candidate to a growing list of shots showing promising effectiveness against Covid-19—setting in motion disparate regulatory and distribution tracks that executives and researchers hope will result in the start of widespread vaccinations by the end of the year.

AstraZeneca and Oxford said their vaccine was as much as 90% effective in preventing the infection without serious side effects in large clinical trials, though they said the vaccine’s efficacy…

Leave a Reply

Your email address will not be published. Required fields are marked *

700 Louisiana Street , Houston TX. 77002
(+1) 832-390-2738
info@gmi-co.com

Follow us:

FREE CONSULTATION

Calls may be recorded for quality and training purposes.

Copyright © GMI 2020